ArticleEar and hearing
Auditory Function and Natural History of 645 Auditory Neuropathy Patients Over a 27-Year Span in China.
Article in Ear and hearing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesOver the past 30 years, significant advancements have been made in auditory neuropathy (AN) research. The study aimed to explore auditory function and the natural history of AN from neonates to adulthood based on a large Chinese AN patient population.
designThis retrospective case series included 645 patients diagnosed with AN at our institution, the Chinese PLA General Hospital, over a 27-year period from January 1997 to December 2023. All patients had an absent or abnormal auditory brainstem response (ABR), normal or slightly altered otoacoustic emissions and/or cochlear microphonics (CM), and binaural onset.
resultsThe study enrolled patients who were from 29 provinces and 11 different ethnic groups in China. The diagnostic rate of AN has ranged from 1 case per year to 44 diagnoses per year. The study assessed the typical auditory characteristics of individuals at various ages at diagnosis. Statistically significant differences were found in the elicitation rates of ABR, distortion product otoacoustic emissions, acoustic stapedius reflex threshold, pure-tone average, 40 Hz auditory event-related potential, and progress of speech discrimination scores in AN patients from neonates to adulthood; however, the elicitation of CM ranged from 96.36 to 100% from neonates to adulthood. A relatively large proportion of AN patients had hearing loss predominantly affecting the lower frequency range. Follow-up results showed that patients with AN had stable abnormal or absent ABR, distortion product otoacoustic emissions gradually disappeared, but CM remained stable, and poor speech discrimination scores persisted. Distinct clinical profiles were observed in patients with AN carrying pathogenic or likely pathogenic mutations, including OTOF, AIFM1, ATP1A3, WFS1 , and OPA1 . OTOF and ATP1A3 mutation carriers had early onset and poor hearing thresholds, while AIFM1 had later onset and better hearing thresholds by multiple comparisons. Interventions included hearing aids with mainly bilateral interventions, and cochlear implants with predominantly unilateral intervention. Cochlear implant recipients showed lower diagnostic and onset ages and superior aided hearing thresholds compared with hearing aid users.
conclusionsAdvances in disease awareness, hearing screening, and diagnostic methods have enabled early detection and diagnosis of AN. Follow-up results highlighted the importance of CM in evaluating the function of outer hair cells. AN patients experienced a higher frequency of hearing loss progression while maintaining poor, unchangeable speech recognition ability. This study elucidates the multifaceted nature of AN, thereby establishing a more comprehensive understanding of the diagnosis and management of AN. Moreover, it serves as a pivotal reference for guiding counseling and evaluating the prognoses of clinical AN patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.